Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-0509
    Keywords: Renal biopsy complications ; Biopsy complications, imaging ; Us follow-up
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Among 230 patients undergoing ultrasound (US) guided renal biopsy, 218 had postbiopsy sonography. Clinical records were reviewed to correlate symptoms to US findings. In each case of large hematoma (thickness above 1 cm), all postbiopsy sonographic studies were analyzed to look for findings indicative of unfavorable outcome. A total of 96 subcapsular/perirenal hematomas were found. Large hematomas were observed in 20 patients (20/230=8.7%), seven of these (3%) were severely symptomatic. In the absence of clinical signs of bleeding, no patient had clinical consequences. In the presence of clinical signs of bleeding, serious complications occurred only in patients with large hematomas. US thickness of retroperitoneal hematoma correlated to clinical outcome: whenever measured thickness was less than 2 cm, clinical evolution was very favorable, whereas a thickness above 2 cm was invariably associated to clinical signs of bleeding. In six of seven cases of thickness exceeding 3 cm, severe complications developed. An unfavorable evolution was associated with increasing thickness and an echogenicity inappropriate with respect to the time elapsed since biopsy. Hydroureteronephrosis, peritoneal effusion, and anomalous vascular images were indicators of deterioration. We conclude that sonography is indicated only for symptomatic patients and that the monitoring of both thickness and changing echogenicity of retroperitoneal blood collections supplements clinical follow-up.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    International archives of occupational and environmental health 44 (1979), S. 127-132 
    ISSN: 1432-1246
    Keywords: Chelatable lead ; Lead in blood ; Lead in urine
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Chelatable lead (PbU-EDTA) is the best indicator of lead concentration at the critical organ level (indicator of dose). However, since this test is not easily applicable for the biological monitoring of lead-exposed subjects, the current practice is to determine lead in blood (PbB) and/or in urine (PbU). But these tests are indicators of exposure and not of dose. To analyze the reliability of PbB and PbU in estimating lead dose, the relationships between PbU-EDTA and PbB and between PbU-EDTA and PbU were studied in two groups of male lead workers: 48 currently exposed and 45 with past exposure to lead. In currently exposed workers the correlation between PbU-EDTA and PbB and between PbU-EDTA and PbU was very close (r = 0.85, r = 0.74, respectively); in past exposed workers the correlation with PbU-EDTA was decidedly lower for PbB (r = 0.54) and not significant for PbU (r = 0.29). In both cases the relationship between the variables was linear. In the previously exposed men, PbB displayed lower values than those found in currently exposed men. These results indicate that both PbB and PbU allow an indirect estimation to be made of the internal dose in currently exposed subjects, whereas the tests cannot be used for this purpose in subjects who have long since ceased to be exposed. In these cases chelatable lead must be determined.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...